abacavir

Generic: abacavir

Labeler: major pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name abacavir
Generic Name abacavir
Labeler major pharmaceuticals
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

abacavir sulfate 300 mg/1

Manufacturer
Major Pharmaceuticals

Identifiers & Regulatory

Product NDC 0904-6874
Product ID 0904-6874_6efd47b2-b1f2-4c48-b741-23d2ebfdd1d9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077844
Listing Expiration 2026-12-31
Marketing Start 2012-12-17

Pharmacologic Class

Classes
cytochrome p450 1a1 inhibitors [moa] human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc] nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 09046874
Hyphenated Format 0904-6874

Supplemental Identifiers

RxCUI
242679
UNII
J220T4J9Q2

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name abacavir (source: ndc)
Generic Name abacavir (source: ndc)
Application Number ANDA077844 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 30 BLISTER PACK in 1 CARTON (0904-6874-04) / 1 TABLET, FILM COATED in 1 BLISTER PACK
  • 50 BLISTER PACK in 1 CARTON (0904-6874-06) / 1 TABLET, FILM COATED in 1 BLISTER PACK
source: ndc

Packages (2)

Ingredients (1)

abacavir sulfate (300 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6efd47b2-b1f2-4c48-b741-23d2ebfdd1d9", "openfda": {"unii": ["J220T4J9Q2"], "rxcui": ["242679"], "spl_set_id": ["4b286ec6-68a7-4ec0-af07-5a27ec9cb35d"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (0904-6874-04)  / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0904-6874-04", "marketing_start_date": "20121217"}, {"sample": false, "description": "50 BLISTER PACK in 1 CARTON (0904-6874-06)  / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0904-6874-06", "marketing_start_date": "20121217"}], "brand_name": "Abacavir", "product_id": "0904-6874_6efd47b2-b1f2-4c48-b741-23d2ebfdd1d9", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 1A1 Inhibitors [MoA]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "0904-6874", "generic_name": "Abacavir", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abacavir", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "300 mg/1"}], "application_number": "ANDA077844", "marketing_category": "ANDA", "marketing_start_date": "20121217", "listing_expiration_date": "20261231"}